About BioVendor
BioVendor is a company based in Asheville (United States) founded in 1992. It operates as a B2B2C, Reseller / Distribution, and HealthTech. BioVendor has completed 3 acquisitions, including DIAsource ImmunoAssays, Immunolab and Oxford Biosystems. BioVendor offers products and services including Immunoassays, Antibodies & Recombinant Proteins, Next Generation Sequencing Kits, and Endotoxin Detection & Removal.
- Headquarter Asheville, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biovendor – Laboratorni Medicina A.S.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$251 K (USD), Grant
Jan 01, 2023
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
DIAsource ImmunoAssays
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioVendor
BioVendor offers a comprehensive portfolio of products and services, including Immunoassays, Antibodies & Recombinant Proteins, Next Generation Sequencing Kits, and Endotoxin Detection & Removal. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Validated kits are provided for reliable diagnostic results.
High purity reagents are offered for research accuracy.
Advanced kits are developed for genetic cancer profiling.
Solutions are provided for safe biological sample processing.
Funding Insights of BioVendor
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $250,999
-
First Round
First Round
(01 Jun 2015)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Grant - BioVendor | Valuation |
investors |
|
| May, 2021 | Amount | Grant - BioVendor | Valuation |
investors |
|
| Feb, 2019 | Amount | Grant - BioVendor | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioVendor
BioVendor has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Portál veřejné správy. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
A digital platform for public administration services in Czech Republic.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioVendor
BioVendor has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include DIAsource ImmunoAssays, Immunolab and Oxford Biosystems. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnostic kits and reagents are manufactured for therapeutic areas.
|
2001 | ||||
|
DIAsource Vitamin D expert in RIA, ELISA & Antibodies
|
1996 | ||||
|
Immunoassay diagnostic kits
|
1992 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - BioVendor
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biovendor Comparisons
Competitors of BioVendor
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biovendor
Frequently Asked Questions about BioVendor
When was BioVendor founded?
BioVendor was founded in 1992 and raised its 1st funding round 23 years after it was founded.
Where is BioVendor located?
BioVendor is headquartered in Asheville, United States. It is registered at Asheville, North Carolina, United States.
What does BioVendor do?
BioVendor is involved in the development, production, and distribution of in-vitro diagnostic (IVD) products and technologies for laboratory automation. The company focuses on immunoassays, recombinant proteins, antibodies, and endotoxin detection and removal products. Solutions are provided for various research and diagnostic needs, including next-generation sequencing, molecular diagnostics, and point-of-care testing. Operations span across biotechnology and healthcare sectors, with an emphasis on innovative diagnostics for conditions like chronic kidney disease and atopic dermatitis. Products are distributed globally through a network of partners and distributors.
What products or services does BioVendor offer?
BioVendor offers Immunoassays, Antibodies & Recombinant Proteins, Next Generation Sequencing Kits, and Endotoxin Detection & Removal.
How many acquisitions has BioVendor made?
BioVendor has made 3 acquisitions, including DIAsource ImmunoAssays, Immunolab, and Oxford Biosystems.
Who are BioVendor's investors?
BioVendor has 2 investors. Key investors include European Union, and Portál veřejné správy.